[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:hepatitis-b-infection":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":117,"states":124},"Hepatitis B Infection",17,12,[8,16,22,28,34,41,48,54,60,66,72,78,84,92,98,105,111],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07024641","A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection",[12],"Phase 1","RECRUITING","2026-08-26T02:19:19.162260Z","2026-05-05T02:43:29.364387Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT04843852","TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B",[12],"2026-08-26T02:17:16.126291Z","2026-05-05T02:43:29.327590Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT06680232","Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B",[12],"2026-08-26T02:16:22.235886Z","2026-05-05T02:43:27.640734Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT05856890","HepB mAb19 in Individuals With Chronic Hepatitis B Infection",[12],"2026-08-26T02:16:31.714843Z","2026-05-05T02:43:27.491318Z",{"nct_id":35,"title":36,"phases":37,"status":13,"updated_at":39,"content_modified":40},"NCT05304234","Liver Cancer Disparities in American Indian and Alaska Native Persons",[38],"Phase 2","2026-08-26T02:17:28.381459Z","2026-04-29T02:57:57.073818Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":46,"content_modified":47},"NCT06084234","National Liver Cancer Screening Trial",[45],"Phase 4","2026-08-26T02:16:09.452956Z","2026-05-05T02:43:28.172694Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT07449091","Adaptability of an Undetectable = Untransmissible Model for HBV",[],"2026-08-26T02:17:20.511551Z","2026-05-13T02:55:06.705617Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT07317687","Rapid HIV, Hep C, and Syphilis Screening in a Rural Street Medicine Clinic",[],"2026-08-26T02:17:05.172421Z","2026-05-13T02:55:06.685832Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT01206920","The DC Cohort Longitudinal HIV Status Neutral Study",[],"2026-08-26T02:19:20.945539Z","2026-05-13T02:55:06.070631Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT00404989","Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.",[],"2026-08-26T02:18:47.742071Z","2026-05-13T02:55:06.035942Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT03025074","Blood Collection Biorepository for Liver Disease Research",[],"2026-08-26T02:16:46.951087Z","2026-05-13T02:55:06.105869Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":82,"content_modified":83},"NCT00001971","Evaluation of Patients With Liver Disease",[],"2026-08-26T02:19:21.761002Z","2026-05-13T02:55:06.028720Z",{"nct_id":85,"title":86,"phases":87,"status":89,"updated_at":90,"content_modified":91},"NCT07658976","Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy",[88],"Phase 3","NOT_YET_RECRUITING","2026-08-26T02:17:14.343713Z","2026-07-05T03:45:20.257985Z",{"nct_id":93,"title":94,"phases":95,"status":89,"updated_at":96,"content_modified":97},"NCT07031219","HIV\u002FHBV\u002FHCV Triple Screening in Primary Care",[],"2026-08-26T02:15:41.377360Z","2026-05-05T02:43:28.652621Z",{"nct_id":99,"title":100,"phases":101,"status":102,"updated_at":103,"content_modified":104},"NCT04954859","Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)",[38],"ACTIVE_NOT_RECRUITING","2026-08-03T03:07:45.344605Z","2026-05-05T02:43:29.709291Z",{"nct_id":106,"title":107,"phases":108,"status":102,"updated_at":109,"content_modified":110},"NCT02932150","Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection",[38],"2026-08-03T01:59:18.089574Z","2026-05-05T02:43:27.089722Z",{"nct_id":112,"title":113,"phases":114,"status":102,"updated_at":115,"content_modified":116},"NCT02995252","The HOPE Study: Characterizing Patients With Hepatitis B and C",[],"2026-08-03T03:20:51.997416Z","2026-05-13T02:55:06.104837Z",[118,121],{"biomarker":4,"count":119,"slug":120},5,"hepatitis-b-infection",{"biomarker":122,"count":119,"slug":123},"Hepatitis B Virus HBsAg Surface Protein Antigen","hepatitis-b-virus-hbsag-surface-protein-antigen",[125,129,132,135,139,143],{"state":126,"count":127,"slug":128},"New York",6,"new-york",{"state":130,"count":119,"slug":131},"California","california",{"state":133,"count":119,"slug":134},"Maryland","maryland",{"state":136,"count":137,"slug":138},"Texas",4,"texas",{"state":140,"count":141,"slug":142},"Massachusetts",3,"massachusetts",{"state":144,"count":141,"slug":145},"Virginia","virginia"]